Stephane De Wit

Summary

Affiliation: CHU Saint-Pierre
Country: Belgium

Publications

  1. pmc Limited cross-border infections in patients newly diagnosed with HIV in Europe
    Dineke Frentz
    Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
    Retrovirology 10:36. 2013
  2. pmc HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
    Ina Vandenbroucke
    Tibotec Virco Virology BVBA, Mechelen, Belgium
    AIDS Res Ther 7:4. 2010
  3. pmc Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008
  4. pmc High-risk human papillomavirus infection in HIV-positive African women living in Europe
    Deborah Konopnicki
    Department of Infectious Diseases, Saint Pierre University Hospital, Brussels Free University, Brussels, Belgium
    J Int AIDS Soc 16:18023. 2013
  5. ncbi request reprint Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients
    Stephane De Wit
    St Pierre University Hospital, Brussels, Belgium
    AIDS 18:2330-1. 2004
  6. doi request reprint Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
    Stephane De Wit
    Division of Infectious Diseases, Saint Pierre University Hospital, Brussels, Belgium
    AIDS 25:1332-3. 2011
  7. doi request reprint Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection
    Marcel Nkuize
    Clinic of Hepato gastroenterology, ULB, Brussels, Belgium
    Helicobacter 17:153-9. 2012
  8. pmc Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study
    Nicolas Dauby
    Division of Infectious Diseases, CHU St Pierre, Universite Libre de Bruxelles, Brussels, Belgium
    J Int AIDS Soc 14:16. 2011
  9. doi request reprint Response to combination antiretroviral therapy: variation by age
    Caroline A Sabin
    AIDS 22:1463-73. 2008
  10. ncbi request reprint Combination antiretroviral therapy and the risk of myocardial infarction
    Nina Friis-Møller
    N Engl J Med 349:1993-2003. 2003

Detail Information

Publications16

  1. pmc Limited cross-border infections in patients newly diagnosed with HIV in Europe
    Dineke Frentz
    Department of Virology, Erasmus Medical Center, Rotterdam, The Netherlands
    Retrovirology 10:36. 2013
    ..In this study, phylogenetic associations among HIV of newly diagnosed patients were determined across Europe...
  2. pmc HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays
    Ina Vandenbroucke
    Tibotec Virco Virology BVBA, Mechelen, Belgium
    AIDS Res Ther 7:4. 2010
    ..While good concordance was observed between gp120 phenotyping and prediction of R5-tropic virus, the results suggest that accurate prediction of X4-tropic virus would require further algorithm development...
  3. pmc Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
    Stephane De Wit
    Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
    Diabetes Care 31:1224-9. 2008
    ....
  4. pmc High-risk human papillomavirus infection in HIV-positive African women living in Europe
    Deborah Konopnicki
    Department of Infectious Diseases, Saint Pierre University Hospital, Brussels Free University, Brussels, Belgium
    J Int AIDS Soc 16:18023. 2013
    ..Cervical infection with high-risk human papillomavirus (HRHPV) induces cervical cancer and is present in 14% of women in Europe. We assessed the prevalence and incidence of cervical HRHPV in a cohort of HIV-positive women living in Belgium...
  5. ncbi request reprint Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients
    Stephane De Wit
    St Pierre University Hospital, Brussels, Belgium
    AIDS 18:2330-1. 2004
    ..However, there was a significant difference in the median CD4 cell increase at month 24. Whether this is caused by viral or immune factors warrants further investigation...
  6. doi request reprint Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
    Stephane De Wit
    Division of Infectious Diseases, Saint Pierre University Hospital, Brussels, Belgium
    AIDS 25:1332-3. 2011
    ..controls, with no difference in high-sensitivity C-reactive protein (hsCRP) and CD4. These results suggest that atorvastatin reduces the level of immune activation in patients with undetectable viral load...
  7. doi request reprint Comparison of demographic characteristics and upper gastrointestinal endoscopy findings in HIV-positive, antiretroviral-treated patients with and without Helicobacter pylori coinfection
    Marcel Nkuize
    Clinic of Hepato gastroenterology, ULB, Brussels, Belgium
    Helicobacter 17:153-9. 2012
    ..Pylori coinfection...
  8. pmc Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study
    Nicolas Dauby
    Division of Infectious Diseases, CHU St Pierre, Universite Libre de Bruxelles, Brussels, Belgium
    J Int AIDS Soc 14:16. 2011
    ..Non-AIDS-defining malignancies (NADM) are becoming a major cause of mortality in the era of highly active antiretroviral therapy. We wished to investigate the incidence, risks factors and outcome of NADM in an urban cohort...
  9. doi request reprint Response to combination antiretroviral therapy: variation by age
    Caroline A Sabin
    AIDS 22:1463-73. 2008
    ..To provide information on responses to combination antiretroviral therapy in children, adolescents and older HIV-infected persons...
  10. ncbi request reprint Combination antiretroviral therapy and the risk of myocardial infarction
    Nina Friis-Møller
    N Engl J Med 349:1993-2003. 2003
    ..It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction...
  11. doi request reprint Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006
    Jurgen Vercauteren
    Rega Institute for Medical Research and University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium
    AIDS Res Hum Retroviruses 24:355-62. 2008
    ..e., zidovudine, lamivudine, and efavirenz. Our results support the implementation of genotypic resistance testing as a standard of care in all treatment-naive patients in Belgium...
  12. ncbi request reprint Class of antiretroviral drugs and the risk of myocardial infarction
    Nina Friis-Møller
    University of Copenhagen, Copenhagen, Denmark
    N Engl J Med 356:1723-35. 2007
    ..We conducted a study to investigate the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction...
  13. ncbi request reprint Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
    Rainer Weber
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital, CH 809a Zurich, Switzerland
    Arch Intern Med 166:1632-41. 2006
    ..An increasing proportion of deaths among human immunodeficiency virus (HIV)-infected persons with access to combination antiretroviral therapy (cART) are due to complications of liver diseases...
  14. ncbi request reprint Predictors of hypertension and changes of blood pressure in HIV-infected patients
    Rodolphe Thiebaut
    INSERM E0338 epsilont U593, ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    Antivir Ther 10:811-23. 2005
    ..We assessed predictors of changes in systolic (SBP) and diastolic (DBP) blood pressure during follow-up and of the development of hypertension in HIV-infected individuals...
  15. ncbi request reprint Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
    Amanda Mocroft
    Royal Free Centre for HIV Medicine and Dept Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
    AIDS 19:2117-25. 2005
    ..Increases in deaths due to liver-related disease (LRD) among HIV-infected individuals have been reported although the influence of combination antiretroviral therapy (cART) on LRD is controversial...
  16. pmc Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    Caroline A Sabin
    Lancet 371:1417-26. 2008
    ..Our aim was to explore whether exposure to such drugs was associated with an excess risk of myocardial infarction in a large, prospective observational cohort of HIV-infected patients...